Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
113,177,462
-
Total 13F shares
-
636,030
-
Share change
-
-573,875
-
Total reported value
-
$757,000
-
Price per share
-
$1.19
-
Number of holders
-
11
-
Value change
-
-$869,302
-
Number of buys
-
7
-
Number of sells
-
4
Institutional Holders of Viking Therapeutics, Inc. - COMMON STOCK (VKTX) as of Q4 2016
As of 31 Dec 2016,
Viking Therapeutics, Inc. - COMMON STOCK (VKTX) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
636,030 shares.
The largest 10 holders included
VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, GRT CAPITAL PARTNERS L.L.C., GEODE CAPITAL MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, NORTHERN TRUST CORP, MORGAN STANLEY, Acrospire Investment Management LLC, MANUFACTURERS LIFE INSURANCE COMPANY, THE, and REILLY FINANCIAL ADVISORS, LLC.
This page lists
11
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.